888 575 9695        Contact Us        Sign in

Legal Information

Financial Conflict of Interest (FCOI) Policy

Please view our policy here.

Patents and Limited Label License

The 6xHis tag is licensed from Hoffmann-La Roche, Inc., Nutley, NJ and/or Hoffmann-LaRoche Ltd., Basel, Switzerland and is provided only for the use in research.  Information about licenses for commercial use is available from

QIAGEN Strasse 1
D-40724 Hilden, Germany

ClearColi® Competent Cells are subject to US Patent 8,303,964 and other US and foreign pending patents. For a full description of the limited use license and licensing information about these cells, please go to the ClearColi licensing page.

Lucigen’s vectors incorporating the CloneSmart® transcription-free cloning technology are the subject of U.S. Patent No. 6,709,861 and pending patent applications owned by Lucigen Corporation. The consideration paid for these products grants a Limited License to use the purchased amount of products pursuant to the terms set forth in the Limited Label License. Except where stated otherwise, the Limited License specifically excludes manufacture of additional vector derived from these kits. Academic, Not-for-Profit and For-Profit institutions acquire certain limited nontransferable rights with the purchase of these products. A complete description of the Limited License rights and limitations accompanies these products and is available from Lucigen on request. Broader licenses to use these patented vectors for commercial purposes are also available. Please contact customer service for details.

CopyControl™ and CopyCutter™ Products are covered by U.S. Patent No. 5,874,259 licensed to Epicentre® (an Illumina® company) and by U.S. Patent No. 7,138,267 for specific CopyControl cell lines. By purchasing CopyControl systems or vectors, the purchaser receives the right to use the product purchased from Lucigen or clones obtained therefrom solely for life science research. Purchase of these products does not grant rights to: (1) offer products, components of products, or any derivatives thereof for resale; or (2) to distribute or transfer the products, components of products, or derivatives thereof to third parties

Lucigen’s CopyRight® vectors and Replicator™ competent cells are covered by U.S. Patent No. 5,874,259 and patents-pending licensed to Lucigen. By purchasing these products, the purchaser receives a limited use license for life science research applications.

Some applications in which Lucigen’s EconoTaq® DNA Polymerase can be used may be covered by patents issued and applicable in the United States and certain other countries. Because purchase of this product does not include a license to perform any patented application, users of these products may be required to obtain a patent license depending upon the particular application in which the product is used. The PCR process is the subject of European Patent Nos. 201,184 and 200,262 owned by Hoffman-LaRoche. Those patents expired on March 28, 2006. The corresponding PCR process patents in the United States expired on March 29, 2005.

EZ-Tn5™ Transposon Tools for in vitro transposon insertion are covered by U.S. Patent Nos. 5,925,545; 5,948,622; 5,965,443, and 6,437,109; and other patents issued or pending, exclusively licensed or assigned to Epicentre® (an Illumina® company). These products are accompanied by a limited nonexclusive license for the purchaser to use the purchased product(s) solely for in vitro transposon insertion for life science research. Purchase of these products does not grant rights to: (1) offer products, components of products, or any derivatives thereof for resale; or (2) to distribute or transfer the products, components of products, or any derivatives thereof to third parties. Contact Epicentre® (an Illumina® company) for information on licenses for uses other than life science research.

Loop-Mediated Amplification (LAMP): Lucigen is a fully licensed provider of LAMP reagents for research use. Patents WO 00/28082, WO 01/34790, and WO 01/77317 regarding the LAMP method are owned by the Eiken Chemical Co. Ltd. OmniAmp™ , LavaLAMP™ and Bst Polymerase, Exonuclease minus are sold by Lucigen under license for use in LAMP for research use only. The products may not be used for LAMP-based human or diagnostic purposes without obtaining a license from Eiken. US Patent 8093030 for LavaLAMP and OmniAmp is owned by Lucigen Corp.

It is the sole responsibility of the buyer to ensure that use of the product does not infringe the patent rights of third parties. If the purchaser is not willing to accept these use limitations, Lucigen Corporation is willing to accept return of the product for a full refund.

OverExpress™ products are sold for research use only by nonprofit and commercial entities under an exclusive license issued to Lucigen Corporation by Imaxio, S.A. under U.S. Patent No. 6,361,966, AU Patent No. 716694, and pending patent applications. Commercial use of OverExpress to produce a product or service for sale requires a separate license. Contact:

IMAXIO Business Development Director
Biopôle Clermont-Limagne
63360 Saint Beauzire, France
Fax: + 33 473 644 393
E-mail: overexpress@imaxio.com

SUMO Protease is manufactured and supplied by LifeSensors, Inc.

Patent protection for Sygnis' TthPrimPol and methods associated with its use is pending. Patent protection pending for Sygnis' SunScript™ Reverse Transcriptase RNaseH- and methods associated with its use.

Use of Transposome™ Complexes for in vivo Transposon Insertion, including, but not limited to EZ-Tn5™ Transposome™ complexes, is covered by U.S. Patent Nos. 6,159,736, and 6,294,385; European Patent No. 1115856 and other patents issued or pending, exclusively licensed to Epicentre® (an Illumina® company). These products are accompanied by a limited nonexclusive license for nonprofit organizations to use the purchased products solely for life science research. Specifically, researchers at nonprofit organizations may use these products in their research and they may transfer derivatives of the products to colleagues at other nonprofit organizations provided that such colleagues agree in writing to be bound by the terms and conditions of this label license. Researchers may not transfer these products or its derivatives to researchers at other organizations that are not nonprofit organizations without the express written consent of Epicentre® (an Illumina® company) and without those entities having an express license from Epicentre® (an Illumina® company) for the use of the products. Other than as specifically provided here, an authorized transferee of these products shall have no right to transfer these products or its derivatives to any other person or entity. A nonprofit organization performing research using this product for a for-profit organization shall also be considered for-profit. For-profit entities purchasing these products shall have three (3) months to evaluate the products in their research. Thereafter, such for-profit entities shall either contact Epicentre® (an Illumina® company) and take a license for their continued use of the products or destroy the products and all derivatives thereof. Please contact Epicentre® (an Illumina® company) with respect to licenses for commercial use, including manufacturing, therapeutic, or diagnostic use.

Use of TypeOne™ Restriction Inhibitor for increasing transformation efficiencies in bacterial strains with type I restriction and modification (R-M) system is covered by U.S. Patent No. 7,101,713 assigned to Epicentre® (an Illumina® company). This product is accompanied by a limited nonexclusive license for the purchaser to use the purchased product solely for life science research. Contact Epicentre for information on licenses to other uses.


Accura, BigEasy, ClearColi, CloneSmart, CopyRight, DNATerminator, DuraScribe, E. CLONI , EconoTaq, ExCyto, Expresso, HI-Control, Lucigen, NanoClone, NxGen, NxSeq, OmniAmp, pETite, pJAZZ, pSMART, PyroPhage, PyroScript, and Taq98 are registered trademarks of Lucigen Corporation.

AmpliScribe, BAC-Optimized Replicator, BiotinXCell, Blue/White cloning without the blues, ChimeraFree, ClariLight, CloneDirect, CloneID, CopyControl, CopyCutter, CloneSmart, cSMART, EC100, EC100D, eLucidations, eLucidator, End-It, Endura, EPI300, EPI400, EZ-Tn5, Fast-Link, GapFree, GELase, Gel-Ready, LuciNet, MaxPlax, MessageBOOSTER, OverExpress, pAviTag, PCR SMART, pEZ, pEZSeq, pGC, pLEXX-AK, pRANGER, pRham, pTrueBlue, Replicator, SelecTEV, Softag, T7-Flash, TargetAmp, TaqSelect, The Molecular Cloning Company, Transformance, TransforMax, TSA, TypeOne, and UltraClone are trademarks of Lucigen Corporation.

TruePrime is a trademark of SYGNIS AG or one of its subsidiaries (SYGNIS Bioscience GmbH & Co. KG or SYGNIS Biotech, S.L.U.). SunScript is a trademark of SYGNIS AG or one of its subsidiaries (SYGNIS Bioscience GmbH & Co. KG or SYGNIS Biotech, S.L.U.).

Hydroshear and GeneMachines are trademarks of Genomic Solutions, Inc. Vent is a trademark of New England Biolabs, Inc. pGEM is a trademark of Promega Corporation. TOPO, TA, Zero Blunt, DH5a, and DH10B are trademarks of Invitrogen Corporation. pCC1BAC is a trademark of Epicentre Technologies Corporation. MicroPulser, and Gene Pulser are trademarks of BioRad Laboratories, Inc. OverExpress is a trademark of Imaxio, S.A.


This site is a copyrighted publication of Lucigen Corporation. All rights are reserved.

Use Restriction

Lucigen’s products are for research or laboratory use only and are not to be administered to humans or animals or used for pharmaceutical, in vitro diagnostic, or commercial purposes without written permission. Inquiries related to additional uses of Lucigen’s products are welcomed. Lucigen shall not be responsible for injury or damages resulting from the use or misuse of any of its products. Persons using the products should be technically qualified as defined in 40 C.F.R. § 720.3(ee) and should follow the Guidelines for Research involving Recombinant DNA Molecules (N.I.H. Guidelines) as presented in the Federal Register, July 5, 1994 (59 FR 34496) and any amendments thereto.


Lucigen warrants that its products will conform to the standards stated in its product specification sheets in effect at the time of shipment. Lucigen will replace, free of charge, any product that does not conform to the specifications. This warranty limits Lucigen’s liability only to the replacement of the product. THIS WARRANTY IS EXCLUSIVE, AND LUCIGEN MAKES NO OTHER WARRANTY, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION, ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. The stated express warranties, and the remedy provided for breach thereof, are in lieu of all other liability or obligations of Lucigen for any damages whatsoever arising out of or in connection with the delivery, use, performance, or the inability to use any of its products. IN NO EVENT SHALL LUCIGEN BE LIABLE UNDER ANY LEGAL THEORY (INCLUDING BUT NOT LIMITED TO CONTRACT, NEGLIGENCE, STRICT LIABILITY IN TORT, OR WARRANTY OF ANY KIND) FOR ANY INDIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL, OR EXEMPLARY DAMAGES (INCLUDING BUT NOT LIMITED TO LOST PROFITS). Without limiting the effect of the preceding sentence, Lucigen’s maximum liability, if any, shall not exceed the purchase price paid by buyer for the product.

Risk Disclosure

Lucigen Corporation makes no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All documents and related graphics are provided "AS IS" without warranty of any kind. Lucigen Corporation hereby disclaims all warranties and conditions with regard to this information, including all implied warranties. In no event shall Lucigen Corporation be liable for any special, indirect or consequential damages of any kind, arising out of or in connection with the use of performance of information available from this server. The technical suggestions and data provided on this web site are based on information we believe to be reliable. They are offered in good faith, but without guarantee, as the conditions and methods of use of our products are beyond our control. THE DOCUMENTS AND RELATED GRAPHICS PUBLISHED ON THIS SERVER COULD INCLUDE TECHNICAL INACCURACIES OR TYPOGRAPHICAL ERRORS. CHANGES ARE PERIODICALLY ADDED TO THE INFORMATION HEREIN, WITHOUT NOTICE.

Lucigen's web site also contains third party information. Such information is, wherever practically possible, marked with the name of the source and does not necessarily represent the opinion of Lucigen. Lucigen does not take any responsibility whatsoever for such third party information.

This web site also contains links to other web sites. Lucigen is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement by Lucigen of the third-party web site. Lucigen does not have any knowledge of the information contained in such other web sites, nor does Lucigen have any control over the content on such web sites. Lucigen therefore does not take any responsibility whatsoever for information contained on other web sites.

Should any viewer of this web site provide information, including personal or feedback data, whether in the form of questions, comments, suggestions, or otherwise, such information shall be subject to Lucigen’s Privacy Policy ».

Exclusive Terms of Sale

Lucigen does not agree to and is not bound by any other terms or conditions, unless those terms or conditions have been expressly agreed to in writing by a duly authorized officer of Lucigen.

Prices are subject to change without notice.

Purchase Order Terms & Conditions for Lucigen Vendors

All Lucigen Purchase Orders are subject to Lucigen's Terms & Conditions »

Welcome to Lucigen!
Please tell us your location: